MedTrace Logo

Coronary Access After Supra-Annular THV Implantation

NCT05075590 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-12-20

No results posted yet for this study

Summary

To determine the optimal technique and equipment for selective coronary engagement specifically following Evolut THV implantation using commissural alignment.

Conditions

  • Coronary Angiography
  • Transcatheter Aortic Valve Replacement

Interventions

DIAGNOSTIC_TEST

Coronary Angiography

Following TAVR, the operators will attempt to selectively engage both the right and left coronary arteries. Catheter choice and engagement technique will be at the discretion of the operator.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • The Centre for Cardiovascular Innovation - Centre d'Innovation Cardiovasculaire (CCI-CIC)

    collaborator UNKNOWN

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Janarthanan Sathananthan, MBChB, MPH · University of British Columbia

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-27
Primary Completion
2024-06-30
Completion
2024-07-31
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05075590 on ClinicalTrials.gov